The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
Open accessAbstract
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understanding of the biological barriers that stand between initial administration of these drugs and their final actions within cells. This review examines some of the key barriers that affect the biodistribution of oligonucleotides both in molecular form and when they are associated with nanocarriers. An understanding of the biological processes underlying these barriers will aid in the design of more effective delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Rab proteins as membrane organizers
Zerial, M., & McBride, H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052055 · Cited by 3,381
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Signaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720
Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System
Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W., & Schneider, W. J. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000245 · Cited by 1,600
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Phagocytosis of Microbes: Complexity in Action
Underhill, D. M., & Ozinsky, A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.103001.114744 · Cited by 1,124
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Rabs and their effectors: achieving specificity in membrane traffic
Grosshans, B. L., Ortiz, D., & Novick, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601617103 · Cited by 1,005
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Cai, H., Reinisch, K., & Ferro-Novick, S. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.005 · Cited by 685
Nucleic-acid therapeutics: basic principles and recent applications
Opalinska, J. B., & Gewirtz, A. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd837 · Cited by 537
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Drug Delivery and Transport to Solid Tumors
Jang, S. H., Wientjes, M. G., Lu, D., & Au, J. L.-S. (2003) · Pharmaceutical Research · doi:10.1023/a:1025785505977 · Cited by 483
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Chemical Modification of siRNAs for In Vivo Use
Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0164 · Cited by 454
Allerson, C. R., Sioufi, N., Jarres, R., Prakash, T. P., Naik, N., Berdeja, A., Wanders, L., Griffey, R. H., Swayze, E. E., & Bhat, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049167j · Cited by 448
ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATION
Chan, J. H., Lim, S., & Wong, W. F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04403.x · Cited by 430
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Self-citationProgress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417
PEG-modified biopharmaceuticals
Bailon, P., & Won, C.-Y. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802650568 · Cited by 366
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y. J., Kim, S., Park, H.-O., & Choi, Y.-C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348
Caveolae-deficient Endothelial Cells Show Defects in the Uptake and Transport of Albumin in Vivo
Schubert, W., Frank, P. G., Razani, B., Park, D. S., Chow, C.-W., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100613200 · Cited by 337
Macrophage complement receptors and pathogen clearance
van Lookeren Campagne, M., Wiesmann, C., & Brown, E. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00981.x · Cited by 332
Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol
Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., & Yokota, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.14 · Cited by 312
Specific and potent RNAi in the nucleus of human cells
Robb, G. B., Brown, K. M., Khurana, J., & Rana, T. M. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb886 · Cited by 311
Positional Effect of Chemical Modifications on Short Interference RNA Activity in Mammalian Cells
Prakash, T. P., Allerson, C. R., Dande, P., Vickers, T. A., Sioufi, N., Jarres, R., Baker, B. F., Swayze, E. E., Griffey, R. H., & Bhat, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050044o · Cited by 285
Biodistribution of phosphodiester and phosphorothioate siRNA
Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251
Yu, R. Z., Kim, T.-W., Hong, A., Watanabe, T. A., Gaus, H. J., & Geary, R. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012401 · Cited by 244
Antisense oligonucleotide-based therapeutics for cancer
Dean, N. M., & Bennett, C. F. (2003) · Oncogene · doi:10.1038/sj.onc.1207231 · Cited by 234
Antisense therapy in oncology: new hope for an old idea?
Tamm, I., Dörken, B., & Hartmann, G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05629-x · Cited by 229
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
De Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · RNA · doi:10.1261/rna.459807 · Cited by 228
van de Water, F. M., Boerman, O. C., Wouterse, A. C., Peters, J. G. P., Russel, F. G. M., & Masereeuw, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009555 · Cited by 217
Sorting Nexins – Unifying Trends and New Perspectives
Carlton, J., Bujny, M., Rutherford, A., & Cullen, P. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00260.x · Cited by 199
Receptor-mediated endocytosis: The intracellular journey of transferrin and its receptor
Dautry-Varsat, A. (1986) · Biochimie · doi:10.1016/s0300-9084(86)80004-9 · Cited by 199
Intra-endosomal membrane traffic
van der Goot, F. G., & Gruenberg, J. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.08.003 · Cited by 197
Manoharan, M. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070849 · Cited by 185
Toxicology of antisense therapeutics
Jason, T. L. H., Koropatnick, J. D., & Berg, R. W. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.017 · Cited by 161
Transendothelial Transport: The Vesicle Controversy
Rippe, B., Rosengren, B.-I., Carlsson, O., & Venturoli, D. (2002) · Journal of Vascular Research · doi:10.1159/000064521 · Cited by 159
Fluiter, K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg185 · Cited by 158
Bijsterbosch, M. K. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.16.3290 · Cited by 154
Microcirculation of tumors Part I: Anatomy, function, and necrosis
Rubin, P., & Casarett, G. W. (1966) · Clinical Radiology · doi:10.1016/s0009-9260(66)80027-2 · Cited by 147
Juliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 145
Self-citationPhosphorothioate Oligodeoxynucleotides: Antisense or Anti-Protein?
Krieg, A. Μ., & Stein, C. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.241 · Cited by 127
Yu, R. Z., Lemonidis, K. M., Graham, M. J., Matson, J. E., Crooke, R. M., Tribble, D. L., Wedel, M. K., Levin, A. A., & Geary, R. S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.005 · Cited by 125
Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
Alam, M. R., Dixit, V., Kang, H. M., Li, Z., Chen, X. S., Trejo, J., Fisher, M. H., & Juliano, R. L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn115 · Cited by 124
Self-citationsiRNA and miRNA processing: new functions for Cajal bodies
Pontes, O., & Pikaard, C. S. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.008 · Cited by 115
Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice
Roberts, J., Palma, E., Sazani, P., Ørum, H., Cho, M., & Kole, R. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.017 · Cited by 114
Pegaptanib in the treatment of wet, age-related macular degeneration.
Vinores, S. A. (2006) · PubMed Central · Cited by 111
Bijsterbosch, M. K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.14.2717 · Cited by 107
Merkel, O. M., Librizzi, D., Pfestroff, A., Schurrat, T., Béhé, M. P., & Kissel, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800408g · Cited by 106
Effective intracellular delivery of oligonucleotides in order to make sense of antisense
Shi, F., & Hoekstra, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.016 · Cited by 101
Lorenz, P. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.582 · Cited by 94
siRNA in human cells selectively localizes to target RNA sites
Berezhna, S. Y., Supeková, Ľ., Supek, F., Schultz, P. G., & Deniz, A. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600148103 · Cited by 90
Vascular endothelium and immune responses: implications for inflammation and angiogenesis
Szekanecz, Z., & Koch, A. E. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00116-9 · Cited by 85
Inhibition of MDR1 expression with altritol-modified siRNAs
FISHER, M. S., Abramov, M., Aerschot, A. A. V., Xu, D., Juliano, R. L., & Herdewijn, P. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1126 · Cited by 81
Self-citationDynamin and receptor‐mediated endocytosis
Damke, H. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00517-0 · Cited by 76
Butler, M., Crooke, R. M., Graham, M. J., Lemonidis, K. M., Lougheed, M., Murray, S. F., Witchell, D. R., Steinbrecher, U. P., & Bennett, C. F. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35317-0 · Cited by 72
Phosphorothioate‐stimulated uptake of short interfering RNA by human cells
Overhoff, M. G., & Sczakiel, G. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400535 · Cited by 58
Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides
Kang, H. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh775 · Cited by 58
Self-citationOn future’s doorstep: RNA interference and the pharmacopeia of tomorrow
Gewirtz, A. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34274 · Cited by 57
Liver Uptake of Phosphodiester Oligodeoxynucleotides Is Mediated by Scavenger Receptors
Biessen, E. A. L., Vietsch, H., Kuiper, J., Bijsterbosch, M. K., & van Berkel, T. J. C. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.262 · Cited by 52
Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide
Detzer, A., Overhoff, M. G., Wünsche, W., Rompf, M., Turner, J. J., Ivanova, G. D., Gait, M. J., & Sczakiel, G. (2009) · RNA · doi:10.1261/rna.1305209 · Cited by 52
Liu, Y., & Franzen, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700421u · Cited by 47
Synthetic oligonucleotides as modulators of inflammation
Klinman, D. M., Shirota, H., Tross, D., Sato, T., & Klaschik, S. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107775 · Cited by 45
Oliveira, S., Høgset, A., & Storm, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898789 · Cited by 43
Mescalchin, A., Detzer, A., Wecke, M., Overhoff, M. G., Wünsche, W., & Sczakiel, G. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.10.1531 · Cited by 40
Hartig, R., Shoeman, R. L., Janetzko, A., Grüb, S., & Traub, P. (1998) · PubMed · Cited by 37
Kang, H. M., Alam, M. R., Dixit, V., Fisher, M. H., & Juliano, R. L. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800270w · Cited by 35
Self-citationScherphof, G. L. (1991) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-75862-1_8 · Cited by 34
Hartig, R., Shoeman, R. L., Janetzko, A., Grüb, S., & Traub, P. (1998) · Biology of the Cell · doi:10.1111/j.1768-322x.1998.tb01050.x · Cited by 27
Epigenetic manipulation of gene expression
Juliano, R. L., Dixit, V., Kang, H. M., Kim, T. Y., Miyamoto, Y., & Xu, D. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501053 · Cited by 25
Self-citation
Cited by
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Cellular uptake and trafficking of antisense oligonucleotides
Crooke, S. T., Wang, S., Vickers, T. A., Shen, W., & Liang, X.-H. (2017) · Nature Biotechnology · doi:10.1038/nbt.3779 · Cited by 582
Strategies, design, and chemistry in siRNA delivery systems
Dong, Y., Siegwart, D. J., & Anderson, D. G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.004 · Cited by 572
RNAi-based therapeutics and tumor targeted delivery in cancer
Kara, G., Calin, G. A., & Ozpolat, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114113 · Cited by 411
Binkhathlan, Z., & Lavasanifar, A. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990076 · Cited by 390
Metadata
- Authors
- Juliano, R., Bauman, J., Kang, H., & Ming, X.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-05-08
- Volume
- 6
- Issue
- 3
- Pages
- 686-695
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2031493003
- Cited by
- 304
- References
- 80
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.